The effects of erk1/2 inhibitor on the chondrogenesis of bone marrow-and adipose tissue-derived multipotent mesenchymal stromal cells

Tissue Engineering - Part A

Volumn 16, Issue 3, 2010, Pages 851-860

  Kim, Hye Joung ^a   Im, Gun Il ^a  

^a Dongguk University Ilsan Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; BONE; CARTILAGE; COLLAGEN; ENZYME ACTIVITY; FLOWCHARTING; ORE PELLETS; PATHOLOGY; PELLETIZING; TISSUE ENGINEERING; TRANSCRIPTION; TRANSCRIPTION FACTORS;

ADIPOSE TISSUE; BONE MARROW; BONE MORPHOGENETIC PROTEIN-7; CARTILAGE TISSUE ENGINEERING; CELL TYPES; CHONDROGENESIS; CHONDROGENIC; COLLAGEN TYPE I; DNA CONTENT; EXTRACELLULAR SIGNAL-REGULATED KINASE; GLYCOSAMINOGLYCANS; IMMUNOHISTOCHEMISTRY; IN-VITRO; MESENCHYMAL STROMAL CELLS; MITOGEN ACTIVATED PROTEIN KINASE; MRNA LEVEL; REAL-TIME PCR; TRANSFORMING GROWTH FACTORS; TYPE I COLLAGEN; TYPE II; TYPE X COLLAGEN;

CELL CULTURE;

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; COLLAGEN; DNA; FLAVONOID; IMIDAZOLE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE INHIBITOR; PROTEOGLYCAN; PYRIDINE DERIVATIVE; TRANSCRIPTION FACTOR;

ADIPOSE TISSUE; ADULT; ARTICLE; BIOSYNTHESIS; BONE MARROW CELL; CELL COUNT; CHONDROGENESIS; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; METABOLISM; MIDDLE AGED; MULTIPOTENT STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL;

ADIPOSE TISSUE; ADULT; BONE MARROW CELLS; CELL COUNT; CHONDROGENESIS; COLLAGEN; DNA; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; GENE EXPRESSION REGULATION; HUMANS; IMIDAZOLES; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELLS; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MULTIPOTENT STEM CELLS; PROTEIN KINASE INHIBITORS; PROTEOGLYCANS; PYRIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROMAL CELLS; TRANSCRIPTION FACTORS;

EID: 77649261440     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0070     Document Type: Article

References (35)

1. Caplan, A.I. Mesenchymal stem cells. J Orthop Res 9, 641, 1991.
2. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
3. Tuan, R.S., Boland, G., and Tuli, R. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 5, 235, 2003.
4. Chen, F.H., Rousche, K.T., and Tuan, R.S. Technology insight: adult stem cells in cartilage regeneration and tissue engineering. Nat Clin Pract Rheumatol 2, 373, 2006.
5. Caplan, A.I. Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng 11, 1198, 2005.
6. Zuk, P.A., Zhu, M., Mizuno, H., Huang, H., Futrell, J.W., Katz, A.J., Benhaim, A.J., Lorenz, H.P., and Hedrick, M.H. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7, 211, 2001.
7. Pelttari, K., Winter, A., Steck, E., Goetzke, K., Hennig, T., Ochs, B.G., Aigner, T., and Richter, W. Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum 54, 3254, 2006.
8. Bohme, K., Winterhalter, K.H., and Bruckner, P. Terminal differentiation of chondrocytes in culture is a spontaneous process and is arrested by transforming growth factor-beta 2 and basic fibroblast growth factor in synergy. Exp Cell Res 216, 191, 1995.
9. Muraglia, A., Cancedda, R., and Quarto, R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113,1161, 2000.
10. Stanton, L.A., Underhill, T.M., and Beier, F. MAP kinases in chondrocyte differentiation. Dev Biol 263, 165, 2003.
11. Hagemann, C, and Blank, J.L. The ups and downs of MEK kinase interactions. Cell Signal 13, 863, 2001.
12. Watanabe, H., de Caestecker, M.P., and Yamada, Y. Transcriptional cross-talk between Smad, ERK1/2, and p38 mi-togen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells. J Biol Chem 276, 14466, 2001.
13. Oh, CD., Chang, S.H., Yoon, Y.M., Lee, S.J., Lee, Y.S., Kang, S.S., and Chun, J.S. Opposing role of mitogen-activated protein kinase subtypes, ERK-1/2 and p38, in the regulation of chondrogenesis of mesenchymes. J Biol Chem 275, 5613, 2000.
14. Hwang, N.S., Varghese, S., Puleo, C, Zhang, Z., and Elis-seeff, J. Morphogenetic signals from chondrocytes promote chondrogenic and osteogenic differentiation of mesenchymal stem cells. J Cell Physiol 212, 281, 2007.
15. Chang, Y., Ueng, S.W., Lin-Chao, S., and Chao, C.C. Involvement of Gas7 along the ERK1/2 MAP kinase and SOX9 pathway in chondrogenesis of human marrow-derived mesenchymal stem cells. Osteoarthritis Cartilage 16, 1403, 2008.
16. Beier, F., Taylor, A.C., and LuValle, P. Raf signaling stimulates and represses the human collagen X promoter through distinguishable elements. J Cell Biochem 72, 549, 1999.
17. Beier, F., Taylor, A.C., and LuValle, P. The Raf-1/MEK/ ERK pathway regulates the expression of the p21(Cipl/Wafl) gene in chondrocytes. J Biol Chem 274, 30273, 1999.
18. Wojnowski, L., Stancato, L.F., Zimmer, A.M., Hahn, H., Beck, T.W., Larner, A.C., Rapp, U.R., and Zimmer, A. Craf-1 protein kinase is essential for mouse development. Mech Dev 76, 141, 1998.
19. Zhen, X., Wei, L., Wu, Q., Zhang, Y., and Chen, Q. Mitogen-activated protein kinase p38 mediates regulation of chondrocyte differentiation by parathyroid hormone. J Biol Chem 276, 4879, 2001.
20. Pang, L., Sawada, T., Decker, S.J., and Saltiel, A.R. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 270,13585, 1995.
21. Cuenda, A., Rouse, J., Doza, Y.N., Meier, R., Cohen, P., Gallagher, T.F., Young, P.R., and Lee, J.C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364, 229, 1995.
22. Barry, F., Boynton, R.E., Liu, B., and Murphy, J.M. Chondrogenic differentiation of mesenchymal stem cells from bone marrow; differentiation- dependent gene expression of matrix components. Exp Cell Res 268, 189, 2001.
23. Im, G.I., Shin, Y.W., and Lee, K.B. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthritis Cartilage 13, 845, 2005.
24. Im, G.I., Jung, N.H., and Tae, S.K. Chondrogenic differentiation of mesenchymal stem cells isolated from patients in late adulthood: the optimal conditions of growth factors. Tissue Eng 12, 527, 2006.
25. Kim, H.J., and Im, G.I. Combination of transforming growth factor-beta-2 and bone morphogenetic protein 7 enhances chondrogenesis from adipose tissue-derived mesenchymal stem cells. Tissue Eng Part A 15, 1543, 2009.
26. Chang, S.H., Oh, CD., Yang, M.S., Kang, S.S, Lee, Y.S., Sonn, J.K., and Chun, J.S. Protein kinase C regulates chondrogenesis of mesenchymes via mitogen-activated protein kinase signaling. J Biol Chem 273, 19213, 1998.
27. Lefebvre, V., Huang, W., Harley, V.R., Goodfellow, P.N., and de Crombrugghe, B. SOX-9 is a potent activator of the chondrocyte-specific enhancer of the pro-alphal(II) collagen gene. Mol Cell Biol 17, 2336, 1997.
28. Castagnola, P., Moro, G., Descalzi-Cancedda, F., and Cancedda, R. Type X collagen synthesis during in vitro development of chick embryo tibial chondrocytes. J Cell Biol 102, 2310, 1986.
29. Enomoto, H., Enomoto-Iwamoto, M., Iwamoto, M., Nomura, S., Himeno, M., Kitamura, Y., Kishimoto, T., and Komori, T. Cbfal is a positive regulatory factor in chondrocyte maturation. J Biol Chem 275, 8695, 2000.
30. De Bari, C, Dell'Accio, F., Tylzanowski, P., and Luyten, F.P. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44, 1928, 2001.
31. Hennig, T., Lorenz, H., Thiel, A., Goetzke, K., Dickhut, A., Geiger F., and Richter, W. Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6. J Cell Physiol 211, 682, 2007.
32. Mwale, F., Stachura, D., Roughley, P., and Antoniou, J. Limitations of using aggrecan and type X collagen as markers of chondrogenesis in mesenchymal stem cell differentiation. J Orthop Res 24, 1791, 2006.
33. Shen, B., Wei, A., Tao, H., Diwan, A.D., and Ma, D.D. BMP-2 enhances TGF-beta3-mediated chondrogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in alginate bead culture. Tissue Eng Part A 15, 1311, 2009.
34. Kim, H.J., and Im, G.I. Chondrogenic differentiation of adipose tissue-derived mesenchymal stem cells: greater doses of growth factor are necessary. J Orthop Res 27, 612, 2009.
35. Kim, H.J., Kim, Y.J., and Im, G.I. Is continuous treatment with transforming growth factor-beta necessary to induce chondrogenic differentiation in mesenchymal stem cells? Cells Tissues Organs 190, 1, 2009.